This is the first time the disease has circulated to a significant extent since pre-pandemic years and in contrast to influenza, it doesn’t follow a predictable pattern apart from resurging every few years.
Ontario Shores Centre for Mental Health Sciences will now be using pharmacogenetic testing for patients with schizophrenia or schizoaffective disorder.